Concepedia

Publication | Open Access

A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 study

DOIFull Paper Access

79

Citations

36

References

2010

Year

Mathilde Hunault, T. Leguay, Xavier Thomas, O. Legrand, Françoise Huguet, Caroline Bonmati, Martine Escoffre‐Barbe, Laurence Legros, Pascal Turlure, Patrice Chevallier,
Haematologica

Abstract

With the drug schedules used in this study, pegylated liposomal doxorubicin did not improve the outcome of elderly patients with acute lymphoblastic leukemia despite reduced toxicities.

References

YearCitations

Page 1